Skip to main content
. 2016 Dec 30;6(1):109–119. doi: 10.1002/cam4.973

Figure 3.

Figure 3

Receiver operating characteristic (ROC) curves for the 5‐miRNA signature to discriminate ESCC patients from NCs. (A) The combined two phases of training and testing stages (140 ESCC vs. 128 NCs); (B) training stage (32 ESCC vs. 32 NCs); (C) testing stage (108 ESCC vs. 96 NCs); (D) external cohort (60 ESCC vs. 60 NCs); (E) patients with stage I and II (104 ESCC vs. 188 NCs). AUC, areas under the curve; ESCC, esophageal squamous cell carcinoma.